Managing Post COVID-19 Patient with Breathlessness

被引:0
|
作者
Wong, Yen Shen [1 ]
Ibrahim, Muhammad Amin [1 ]
Zim, Mohd Arif Mohd [1 ]
Rani, Mohd Fauzi Abdul [1 ]
机构
[1] Univ Teknol MARA UiTM, Fac Med, Sungai Buloh, Selangor, Malaysia
关键词
FIBROSIS;
D O I
10.1155/2022/7512400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Chronic respiratory disease may be associated with severity of coronavirus disease 2019 (COVID-19) infection. We review a case of chronic obstructive pulmonary disease (COPD) patient who developed acute breathlessness post COVID-19 infection, also focusing on the diagnostic approach. Case. A 69-year-old gentleman with background history of COPD GOLD D and ischemic heart disease was admitted with severe COVID-19 infection. He required high-flow nasal cannula upon presentation. A computed tomography pulmonary angiography (CTPA) thorax at day 10 of illness revealed moderate organizing pneumonia (OP) with emphysematous changes, without pulmonary embolism. He received oral baricitinib and intravenous methylprednisolone for 3 days, which was then followed by tapering prednisolone starting dose of 1 mg/kg/day (60 mg/day) with reduction of 10 mg prednisolone every 3 days. COPD pharmacotherapy was optimized with early utilization of dual bronchodilators and inhaled corticosteroid was withheld. He underwent inpatient pulmonary rehabilitation and was discharged with home oxygen therapy. Unfortunately, he was re-admitted after 2 weeks with shortness of breath and fever for 3 days. Blood results revealed leucocytosis with raised C-reactive protein. A repeat CTPA showed increase reticulations and crazy paving pattern with reduction in lung volume. Multidisciplinary team discussion concluded it as interstitial pneumonia with COVID-19 OP and fibrosis progression. Prednisolone was stopped and he responded well with antibiotics. A follow-up at 3 months post COVID-19 infection showed improvement of clinical symptoms with radiological resolution of ground glass changes. Conclusion. Corticosteroid inhaler should be cautioned in this case, in view of recent pneumonia and non-elevated serum eosinophil count. These groups of patients should be closely followed up to unmask interstitial lung disease that may present prior to COVID-19 and worsen post-infection. Optimizing pre-existing medical conditions should be the paramount intervention.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Does virtual group treatment improve symptoms of breathlessness in the post COVID-19 patient population?
    Gore, R.
    Williamson, L.
    Elliott-Cooper, T.
    Roze, K.
    Ramdharry, G.
    Heightman, M.
    Hillman, T.
    Livingston, R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [2] Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19
    Daines, Luke
    Zheng, Bang
    Elneima, Omer
    Harrison, Ewen
    Lone, Nazir I.
    Hurst, John R.
    Brown, Jeremy S.
    Sapey, Elizabeth
    Chalmers, James D.
    Quint, Jennifer K.
    Pfeffer, Paul
    Siddiqui, Salman
    Walker, Samantha
    Poinasamy, Krisnah
    McAuley, Hamish
    Sereno, Marco
    Shikotra, Aarti
    Singapuri, Amisha
    Docherty, Annemarie B.
    Marks, Michael
    Toshner, Mark
    Howard, Luke S.
    Horsley, Alex
    Jenkins, Gisli
    Porter, Joanna C.
    Ho, Ling-Pei
    Raman, Betty
    Wain, Louise V.
    Brightling, Christopher E.
    Evans, Rachael A.
    Heaney, Liam G.
    De Soyza, Anthony
    Sheikh, Aziz
    ERJ OPEN RESEARCH, 2023, 9 (01)
  • [3] Breathlessness and COVID-19: A Call for Research
    Hentsch, Lisa
    Cocetta, Sara
    Allali, Gilles
    Santana, Isabelle
    Eason, Rowena
    Adam, Emily
    Janssens, Jean-Paul
    RESPIRATION, 2021, 100 (10) : 1016 - 1026
  • [4] Managing the dental practice in the post Covid-19 era
    Origo, Lorena
    DENTAL CADMOS, 2022, 90 (07) : 570 - 572
  • [5] Managing COVID-19 post viral Fatigue Syndrome
    Lapp, Charles W.
    John, Joseph F.
    FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR, 2021, 9 (01): : 1 - 8
  • [6] Mucormycosis in a Diabetic Patient Post COVID-19
    Aldelaimi, Afrah A.
    Aldelaimi, Tahrir N.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (03) : ZJ3 - ZJ3
  • [7] Diaphragm strength in COVID-19 patients and breathlessness
    de Boer, Wytze
    Veldman, Carlijn
    Steenbruggen, Irene
    Patberg, Kornelis Wiebe
    Van Den Berg, Jan Willem Karel
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [8] Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
    Virdi, Gurnam
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [9] Managing Tourist Risk, Grief and Distrust Post COVID-19
    O'Malley, Lisa
    Harris, Lloyd C.
    Story, Vicky
    TOURISM AND HOSPITALITY RESEARCH, 2023, 23 (02) : 170 - 183
  • [10] Late Breaking Abstract - Breathlessness post COVID-19 despite improvement in cardiopulmonary health
    Cassar, Mark Philip
    Petousi, Nayia
    Ho, Ling-Pei
    Talbot, Nick P.
    Lewandowski, Adam J.
    Mahmod, Masliza
    Tunnicliffe, Elizabeth M.
    Xie, Cheng
    Piechnik, Stefan
    Ferreira, Vanessa
    Holdsworth, David
    Neubauer, Stefan
    Raman, Betty
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58